Cambridge Investment Research Advisors, Inc. Journey Medical Corp Put Options Transaction History
Cambridge Investment Research Advisors, Inc.
- $29.4 Billion
- Q3 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding DERM
# of Institutions
40Shares Held
2.94MCall Options Held
0Put Options Held
0-
B. Riley Securities, Inc. Los Angeles, CA865KShares$3.81 Million0.36% of portfolio
-
Vanguard Group Inc Valley Forge, PA325KShares$1.43 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny268KShares$1.18 Million0.0% of portfolio
-
American Financial Group Inc180KShares$793,8000.44% of portfolio
-
Pvg Asset Management Corp Golden, CO168KShares$738,8734.17% of portfolio
About Journey Medical Corp
- Ticker DERM
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 11,596,500
- Market Cap $51.1M
- Description
- Journey Medical Corporation focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's marketed products include Qbrexza, a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug to treat...